CCL2 and familial pancreatic carcinoma: CCL2 is known to promote angiogenesis in different cancers [70–72]; hence, MAGEA3-mediated CCL2 overexpression in pancreatic cancer cells (Fig. 4c-e and g) might have also indirectly contributed to the overall tumor growth in vivo, which warrants further investigation.